{"id": "QeDjEOAAAAAJ", "citedby": 24583, "citedby5y": 9361, "hindex": 61, "hindex5y": 40, "i10index": 106, "i10index5y": 89, "coauthors": [], "name": "James Dignam", "affiliation": "Unknown affiliation", "interests": [], "cites_per_year": {"1998": 161, "1999": 231, "2000": 422, "2001": 541, "2002": 542, "2003": 627, "2004": 625, "2005": 812, "2006": 951, "2007": 957, "2008": 979, "2009": 1044, "2010": 1169, "2011": 1170, "2012": 1311, "2013": 1511, "2014": 1525, "2015": 1687, "2016": 1679, "2017": 1614, "2018": 1692, "2019": 1872, "2020": 774}, "publications": [{"bib": {"title": "Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials", "year": "2005"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:foquWX3nUaYC", "citedby": "4029"}, {"bib": {"title": "Polychemotherapy for early breast cancer: an overview of the randomised trials", "year": "1998"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:AXPGKjj_ei8C", "citedby": "1838"}, {"bib": {"title": "A randomized trial of bevacizumab for newly diagnosed glioblastoma", "year": "2014"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:VL0QpB8kHFEC", "citedby": "1733"}, {"bib": {"title": "Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial", "year": "1999"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:M3NEmzRMIkIC", "citedby": "1175"}, {"bib": {"title": "Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors", "year": "1996"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:g5m5HwL7SMYC", "citedby": "1014"}, {"bib": {"title": "Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.", "year": "1998"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:roLk4NBRz8UC", "citedby": "995"}, {"bib": {"title": "Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials", "year": "2005"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:SpbeaW3--B0C", "citedby": "767"}, {"bib": {"title": "Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 \u2026", "year": "2001"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:vRqMK49ujn8C", "citedby": "752"}, {"bib": {"title": "Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less", "year": "2002"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:_B80troHkn4C", "citedby": "599"}, {"bib": {"title": "Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS", "year": "2011"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:0KyAp5RtaNEC", "citedby": "591"}, {"bib": {"title": "Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience", "year": "2001"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:YFjsv_pBGBYC", "citedby": "590"}, {"bib": {"title": "Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight\u2010year update of Protocol B\u201017: intraductal carcinoma", "year": "1999"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:pqnbT2bcN3wC", "citedby": "581"}, {"bib": {"title": "Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer", "year": "1997"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:738O_yMBCRsC", "citedby": "568"}, {"bib": {"title": "Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer", "year": "2009"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:a0OBvERweLwC", "citedby": "383"}, {"bib": {"title": "Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27", "year": "2012"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:epqYDVWIO7EC", "citedby": "375"}, {"bib": {"title": "Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and \u2026", "year": "2009"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:hqOjcs7Dif8C", "citedby": "364"}, {"bib": {"title": "Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer", "year": "2006"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:ZeXyd9-uunAC", "citedby": "345"}, {"bib": {"title": "Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials", "year": "2004"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:IjCSPb-OGe4C", "citedby": "342"}, {"bib": {"title": "Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National \u2026", "year": "1996"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:9Nmd_mFXekcC", "citedby": "310"}, {"bib": {"title": "Radiation with or without antiandrogen therapy in recurrent prostate cancer", "year": "2017"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:NJ774b8OgUMC", "citedby": "302"}, {"bib": {"title": "Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer", "year": "2016"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:2KloaMYe4IUC", "citedby": "272"}, {"bib": {"title": "A pilot study of the vulnerable elders survey\u201013 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who \u2026", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:JV2RwH3_ST0C", "citedby": "258"}, {"bib": {"title": "Breast cancer: factors associated with stage at diagnosis in black and white women", "year": "1993"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:uJ-U7cs_P_0C", "citedby": "248"}, {"bib": {"title": "Obesity, tamoxifen use, and outcomes in women with estrogen receptor\u2013positive early-stage breast cancer", "year": "2003"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:dfsIfKJdRG4C", "citedby": "241"}, {"bib": {"title": "The use and interpretation of competing risks regression models", "year": "2012"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:OU6Ihb5iCvQC", "citedby": "214"}, {"bib": {"title": "Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial", "year": "2019"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:L7CI7m0gUJcC", "citedby": "213"}, {"bib": {"title": "Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes", "year": "2001"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:70eg2SAEIzsC", "citedby": "209"}, {"bib": {"title": "Coronary heart disease mortality and adjuvant tamoxifen therapy", "year": "1997"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:zA6iFVUQeVQC", "citedby": "199"}, {"bib": {"title": "BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy", "year": "2005"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:ufrVoPGSRksC", "citedby": "196"}, {"bib": {"title": "Tamoxifen for early breast cancer: an overview of the randomised trials", "year": "1998"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:MLfJN-KU85MC", "citedby": "196"}, {"bib": {"title": "Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial", "year": "2012"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:URolC5Kub84C", "citedby": "186"}, {"bib": {"title": "Differences in breast cancer prognosis among African\u2010American and Caucasian women", "year": "2000"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:pyW8ca7W8N0C", "citedby": "185"}, {"bib": {"title": "Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer", "year": "2001"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:_FxGoFyzp5QC", "citedby": "177"}, {"bib": {"title": "Choice and interpretation of statistical tests used when competing risks are present", "year": "2008"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:UebtZRa9Y70C", "citedby": "171"}, {"bib": {"title": "Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer", "year": "2017"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:mVmsd5A6BfQC", "citedby": "147"}, {"bib": {"title": "Colorectal cancer model of health disparities: understanding mortality differences in minority populations", "year": "2006"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:M3ejUd6NZC8C", "citedby": "136"}, {"bib": {"title": "Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project", "year": "1999"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:5ugPr518TE4C", "citedby": "130"}, {"bib": {"title": "Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer", "year": "2006"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:8k81kl-MbHgC", "citedby": "119"}, {"bib": {"title": "Is patient travel distance associated with survival on phase II clinical trials in oncology?", "year": "2003"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:kRWSkSYxWN8C", "citedby": "117"}, {"bib": {"title": "Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: variability and changes in tumor tissue over time", "year": "2004"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:WA5NYHcadZ8C", "citedby": "114"}, {"bib": {"title": "RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).", "year": "2013"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:vV6vV6tmYwMC", "citedby": "112"}, {"bib": {"title": "Predictors of competing mortality in advanced head and neck cancer", "year": "2010"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:HE397vMXCloC", "citedby": "111"}, {"bib": {"title": "Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer", "year": "2009"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:xtRiw3GOFMkC", "citedby": "102"}, {"bib": {"title": "A nomogram for individualized estimation of survival among patients with brain metastasis", "year": "2012"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:KxtntwgDAa4C", "citedby": "98"}, {"bib": {"title": "Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites", "year": "2005"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:RGFaLdJalmkC", "citedby": "97"}, {"bib": {"title": "MYC is amplified in BRCA1-associated breast cancers", "year": "2004"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:tKAzc9rXhukC", "citedby": "97"}, {"bib": {"title": "Estrogen receptor \u03b1, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers", "year": "2008"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:K3LRdlH-MEoC", "citedby": "93"}, {"bib": {"title": "How Often Do BRCA Mutation Carriers Tell Their Young Children of the Family's Risk for Cancer? A Study of Parental Disclosure of BRCA Mutations to Minors and \u2026", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:-_dYPAW6P2MC", "citedby": "92"}, {"bib": {"title": "Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910", "year": "2015"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:kNdYIx-mwKoC", "citedby": "91"}, {"bib": {"title": "Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer", "year": "2010"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:ZHo1McVdvXMC", "citedby": "89"}, {"bib": {"title": "Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density", "year": "2013"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:_kc_bZDykSQC", "citedby": "86"}, {"bib": {"title": "Prognosis among African\u2010American women and white women with lymph node negative breast carcinoma: findings from two randomized clinical trials of the National Surgical Adjuvant \u2026", "year": "1997"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:Zph67rFs4hoC", "citedby": "84"}, {"bib": {"title": "Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers", "year": "2008"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:_Ybze24A_UAC", "citedby": "80"}, {"bib": {"title": "Toward optimal screening strategies for older women", "year": "2005"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:LPZeul_q3PIC", "citedby": "76"}, {"bib": {"title": "Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women", "year": "2001"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:L8Ckcad2t8MC", "citedby": "76"}, {"bib": {"title": "p53 as a marker of prognosis in African-American women with breast cancer", "year": "2010"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:hkOj_22Ku90C", "citedby": "72"}, {"bib": {"title": "Mammographic Density and Breast Cancer After Ductal Carcinoma In Situ", "year": "2004"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:iH-uZ7U-co4C", "citedby": "72"}, {"bib": {"title": "Conditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07", "year": "2010"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:uc_IGeMz5qoC", "citedby": "71"}, {"bib": {"title": "Duration of adjuvant tamoxifen therapy", "year": "2001"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:eflP2zaiRacC", "citedby": "67"}, {"bib": {"title": "Benefits and costs of interventions to improve breast cancer outcomes in African American women", "year": "2004"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:RHpTSmoSYBkC", "citedby": "64"}, {"bib": {"title": "Estimating breast cancer\u2010specific and other\u2010cause mortality in clinical trial and population\u2010based cancer registry cohorts", "year": "2009"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:eMMeJKvmdy0C", "citedby": "63"}, {"bib": {"title": "Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials\u2014report of the National Cancer Institute \u2026", "year": "2012"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:eJXPG6dFmWUC", "citedby": "57"}, {"bib": {"title": "Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with radiation therapy (RTOG 9003)", "year": "2011"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:N5tVd3kTz84C", "citedby": "53"}, {"bib": {"title": "Early stopping of a clinical trial when there is evidence of no treatment benefit: protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project", "year": "1998"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:5Ul4iDaHHb8C", "citedby": "49"}, {"bib": {"title": "Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trials", "year": "2003"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:XD-gHx7UXLsC", "citedby": "47"}, {"bib": {"title": "Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer \u2026", "year": "2019"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:TIZ-Mc8IlK0C", "citedby": "46"}, {"bib": {"title": "NCI\u2013RTOG translational program strategic guidelines for the early-stage development of radiosensitizers", "year": "2013"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:q3CdL3IzO_QC", "citedby": "40"}, {"bib": {"title": "Diffusing capacity predicts long-term survival after lung resection for cancer", "year": "2012"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:ZfRJV9d4-WMC", "citedby": "40"}, {"bib": {"title": "Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials", "year": "2011"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:SP6oXDckpogC", "citedby": "40"}, {"bib": {"title": "Semiparametric models for cumulative incidence functions", "year": "2004"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:IWHjjKOFINEC", "citedby": "40"}, {"bib": {"title": "Duration of androgen deprivation in locally advanced prostate cancer: long-term update of NRG oncology RTOG 9202", "year": "2017"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:J-pR_7NvFogC", "citedby": "39"}, {"bib": {"title": "Initial results of a phase III randomized study of high-dose 3DCRT/IMRT versus standard dose 3D-CRT/IMRT in patients treated for localized prostate cancer (RTOG 0126)", "year": "2014"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:k_IJM867U9cC", "citedby": "38"}, {"bib": {"title": "Occurrence of stroke with tamoxifen in NSABP B-24", "year": "2000"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:WF5omc3nYNoC", "citedby": "38"}, {"bib": {"title": "Association of black race with prostate cancer\u2013specific and other-cause mortality", "year": "2019"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:M7yex6snE4oC", "citedby": "37"}, {"bib": {"title": "Baseline comorbidities in a skin cancer prevention trial in Bangladesh", "year": "2013"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:35N4QoGY0k4C", "citedby": "36"}, {"bib": {"title": "Obesity and breast cancer prognosis: an expanding body of evidence", "year": "2004"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:q3oQSFYPqjQC", "citedby": "34"}, {"bib": {"title": "A randomized trial of 79.2 Gy versus 70.2 Gy radiation therapy (RT) for localized prostate cancer.", "year": "2015"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:b0M2c_1WBrUC", "citedby": "33"}, {"bib": {"title": "NRG oncology RTOG 0415: A randomized phase III non-inferiority study comparing 2 fractionation schedules in patients with low risk prostate cancer", "year": "2015"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:RYcK_YlVTxYC", "citedby": "30"}, {"bib": {"title": "Molecular predictors of outcome and response to bevacizumab (BEV) based on analysis of RTOG 0825, a phase III trial comparing chemoradiation (CRT) with and without BEV in \u2026", "year": "2013"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:V3AGJWp-ZtQC", "citedby": "30"}, {"bib": {"title": "Prevention of colorectal cancer and dietary management", "year": "2013"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:Tyk-4Ss8FVUC", "citedby": "29"}, {"bib": {"title": "Disease volumes as a marker for patient response in malignant pleural mesothelioma", "year": "2013"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:Y0pCki6q_DkC", "citedby": "26"}, {"bib": {"title": "Long-term suppression of tumor growth by TNF requires a Stat1-and IFN regulatory factor 1-dependent IFN-\u03b3 pathway but not IL-12 or IL-18", "year": "2004"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:t7zJ5fGR-2UC", "citedby": "26"}, {"bib": {"title": "Bayesian hierarchical multiresolution hazard model for the study of time-dependent failure patterns in early stage breast cancer", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:W5xh706n7nkC", "citedby": "24"}, {"bib": {"title": "\u201cIntrinsic Gene Expression\u201d subtypes correlated with grade and morphometric parameters reveal a high proportion of aggressive basal-like tumors among black women of African \u2026", "year": "2004"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:yB1At4FlUx8C", "citedby": "24"}, {"bib": {"title": "Findings from two decades of National Surgical Adjuvant Breast and Bowel Project clinical trials involving breast cancer patients with negative axillary nodes.", "year": "2002"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:r0BpntZqJG4C", "citedby": "24"}, {"bib": {"title": "Optimization of response classification criteria for patients with malignant pleural mesothelioma", "year": "2012"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:8AbLer7MMksC", "citedby": "22"}, {"bib": {"title": "Joint modelling of longitudinal and multi\u2010state processes: application to clinical progressions in prostate cancer", "year": "2016"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:UeHWp8X0CEIC", "citedby": "20"}, {"bib": {"title": "Promoting the appropriate use of advanced radiation technologies in oncology: summary of a national cancer policy forum workshop", "year": "2017"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:NhqRSupF_l8C", "citedby": "19"}, {"bib": {"title": "A missing data approach to semi\u2010competing risks problems", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:Fu2w8maKXqMC", "citedby": "18"}, {"bib": {"title": "Methods for bounding the marginal survival distribution", "year": "1995"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:ipzZ9siozwsC", "citedby": "18"}, {"bib": {"title": "Individualized dynamic prediction of prostate cancer recurrence with and without the initiation of a second treatment: Development and validation", "year": "2016"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:cFHS6HbyZ2cC", "citedby": "17"}, {"bib": {"title": "Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma", "year": "2013"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:3fE2CSJIrl8C", "citedby": "17"}, {"bib": {"title": "Multiple imputation methods for inference on cumulative incidence with missing cause of failure", "year": "2011"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:yD5IFk8b50cC", "citedby": "15"}, {"bib": {"title": "A multiresolution hazard model for multicenter survival studies: Application to tamoxifen treatment in early stage breast cancer", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:l7t_Zn2s7bgC", "citedby": "15"}, {"bib": {"title": "Investigating the effect of reirradiation or systemic therapy in patients with glioblastoma after tumor progression: a secondary analysis of NRG oncology/radiation therapy \u2026", "year": "2018"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:TFP_iSt0sucC", "citedby": "12"}, {"bib": {"title": "A tissue biomarker\u2013based model that identifies patients with a high risk of distant metastasis and differential survival by length of androgen deprivation therapy in RTOG \u2026", "year": "2014"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:ULOm3_A8WrAC", "citedby": "12"}, {"bib": {"title": "Toward personalized treatment for gastroesophageal adenocarcinoma (GEC): Strategies to address tumor heterogeneity\u2014PANGEA.", "year": "2014"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:XiSMed-E-HIC", "citedby": "12"}, {"bib": {"title": "Race and the prognostic influence of p53 in women with breast cancer", "year": "2012"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:eq2jaN3J8jMC", "citedby": "12"}, {"bib": {"title": "Response: Re: Racial Disparities in Cancer Survival Among Randomized Clinical Trials of the Southwest Oncology Group", "year": "2010"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:vbGhcppDl1QC", "citedby": "12"}, {"bib": {"title": "Efficacy of anti-HER2 agents in combination with adjuvant or neoadjuvant chemotherapy for early and locally advanced HER2-positive breast cancer patients: a network meta-analysis", "year": "2018"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:B3FOqHPlNUQC", "citedby": "11"}, {"bib": {"title": "An evaluation of psychosocial and religious belief differences in a diverse racial and socioeconomic urban cancer population", "year": "2017"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:PR6Y55bgFSsC", "citedby": "11"}, {"bib": {"title": "Bayesian approach for flexible modeling of semicompeting risks data", "year": "2014"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:KlAtU1dfN6UC", "citedby": "11"}, {"bib": {"title": "Long-term outcomes after invasive breast tumor recurrence (IBTR) in women with DCIS in NSABP B-17 and B-24", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:dQ2og3OwTAUC", "citedby": "11"}, {"bib": {"title": "Population-based survival-cure analysis of ER-negative breast cancer", "year": "2010"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:D03iK_w7-QYC", "citedby": "10"}, {"bib": {"title": "The ongoing search for the sources of the breast cancer survival disparity", "year": "2006"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:SeFeTyx0c_EC", "citedby": "10"}, {"bib": {"title": "The role of cancer cooperative groups within the spectrum of cancer care", "year": "2004"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:abG-DnoFyZgC", "citedby": "10"}, {"bib": {"title": "Variation over time and interdependence between disease progression and death among patients with glioblastoma on RTOG 0525", "year": "2015"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:4DMP91E08xMC", "citedby": "9"}, {"bib": {"title": "Patterns of missing mini mental status exam (MMSE) in radiation therapy oncology group (RTOG) brain cancer trials", "year": "2011"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:M05iB0D1s5AC", "citedby": "9"}, {"bib": {"title": "Quality of life in patients with low-risk prostate cancer treated with hypofractionated vs conventional radiotherapy: a phase 3 randomized clinical trial", "year": "2019"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:VaXvl8Fpj5cC", "citedby": "8"}, {"bib": {"title": "Metastasis free survival (MFS) is a surrogate for overall survival (OS) in localized prostate cancer (CaP)", "year": "2016"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:nb7KW1ujOQ8C", "citedby": "8"}, {"bib": {"title": "From efficacy to effectiveness: translating randomized controlled trial findings into treatment standards", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:xtoqd-5pKcoC", "citedby": "8"}, {"bib": {"title": "Conditional survival for patients with colon cancer: an analysis of National Surgical Adjuvant Breast and Bowel Project (NSABP) trials C-03 through C-06", "year": "2006"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:eQOLeE2rZwMC", "citedby": "8"}, {"bib": {"title": "Multiple imputation methods for nonparametric inference on cumulative incidence with missing cause of failure", "year": "2014"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:4fKUyHm3Qg0C", "citedby": "7"}, {"bib": {"title": "Family history of pancreatic cancer in a high-risk cancer clinic: implications for risk assessment", "year": "2008"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:Mojj43d5GZwC", "citedby": "7"}, {"bib": {"title": "DCIS: evidence from radomized trials", "year": "2003"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:JoZmwDi-zQgC", "citedby": "7"}, {"bib": {"title": "Two years of anti-androgen treatment increases other-cause mortality in men receiving early salvage radiotherapy: a secondary analysis of the NRG Oncology/RTOG 9601 randomized \u2026", "year": "2019"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:-FonjvnnhkoC", "citedby": "6"}, {"bib": {"title": "Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features", "year": "2019"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:hMsQuOkrut0C", "citedby": "6"}, {"bib": {"title": "Smoking, age, nodal disease, T stage, p16 status, and risk of distant metastases in patients with squamous cell cancer of the oropharynx", "year": "2019"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:g3aElNc5_aQC", "citedby": "6"}, {"bib": {"title": "Time interval to biochemical failure as a surrogate end point in locally advanced prostate cancer: analysis of randomized trial NRG/RTOG 9202", "year": "2019"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:ILKRHgRFtOwC", "citedby": "6"}, {"bib": {"title": "Disease-free survival (DFS) as a surrogate for overall survival (OS) in localized prostate cancer (CaP).", "year": "2016"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:sSrBHYA8nusC", "citedby": "6"}, {"bib": {"title": "Time-dependent patterns of recurrence after early stage breast cancer: Preliminary observations and methodological issues", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:rO6llkc54NcC", "citedby": "6"}, {"bib": {"title": "Design and analysis of oncology clinical trials", "year": "2006"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:tzM49s52ZIMC", "citedby": "6"}, {"bib": {"title": "NRG oncology/RTOG 0415, phase 3 noninferiority study comparing 2 fractionation schedules in patients with low-risk prostate Cancer: prostate-specific quality of life results", "year": "2016"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:fEOibwPWpKIC", "citedby": "5"}, {"bib": {"title": "Duration of androgen deprivation in locally advanced prostate cancer: long-term update of NRG Oncology/RTOG 9202", "year": "2015"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:j3f4tGmQtD8C", "citedby": "5"}, {"bib": {"title": "NO-046. RTOG 0825: PRIMARY OUTCOME RESULTS FROM A PHASE III RANDOMIZED, PLACEBO CONTROLLED TRIAL EVALUATING BEVACIZUMAB IN NEWLY DIAGNOSED GLIOBLASTOMA", "year": "2013"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:u-x6o8ySG0sC", "citedby": "5"}, {"bib": {"title": "Utilization and costs of non-evidence-based (non-EBM) antineoplastic agents in patients with metastatic colon cancer (mCC).", "year": "2011"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:qxL8FJ1GzNcC", "citedby": "5"}, {"bib": {"title": "Outcomes in white (W) patients (pts) and those of African (A) descent receiving adjuvant therapy for colon cancer (CC)", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:QIV2ME_5wuYC", "citedby": "5"}, {"bib": {"title": "Early stopping of cancer clinical trials", "year": "2001"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:Se3iqnhoufwC", "citedby": "5"}, {"bib": {"title": "Tamoxifen for intraductal cancer", "year": "1999"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:HbR8gkJAVGIC", "citedby": "5"}, {"bib": {"title": "Contamination of individuals by radon daughters: a preliminary study", "year": "1988"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:5awf1xo2G04C", "citedby": "5"}, {"bib": {"title": "Flexible modeling of the hazard rate and treatment effects in long-term survival studies", "year": "2017"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:9vf0nzSNQJEC", "citedby": "4"}, {"bib": {"title": "Comparison of futility monitoring guidelines using completed phase III oncology trials", "year": "2017"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:NaGl4SEjCO4C", "citedby": "4"}, {"bib": {"title": "Integrated phase II/III clinical trials in oncology: A case study", "year": "2012"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:u_35RYKgDlwC", "citedby": "4"}, {"bib": {"title": "Some additional thoughts on time-varying treatment effects in breast cancer", "year": "2011"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:LkGwnXOMwfcC", "citedby": "4"}, {"bib": {"title": "Association of high Gli1 expression with poor survival in head and neck cancer patients treated with radiation therapy (RTOG 9003).", "year": "2010"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:1qzjygNMrQYC", "citedby": "4"}, {"bib": {"title": "Molecular classification of west African breast tumors demonstrates an overrepresentation of hormone receptor negative breast cancer", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:_Qo2XoVZTnwC", "citedby": "4"}, {"bib": {"title": "Breast tumor morphometry in relation to race reveals significant differences among Nigerians, African-Americans and Caucasian Americans", "year": "2004"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:W7OEmFMy1HYC", "citedby": "4"}, {"bib": {"title": "Statistical considerations in assessing molecular markers for cancer prognosis and treatment efficacy", "year": "2002"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:_xSYboBqXhAC", "citedby": "4"}, {"bib": {"title": "A systematic review and recommendation for reporting of surrogate endpoint evaluation using meta-analyses", "year": "2019"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:KUbvn5osdkgC", "citedby": "3"}, {"bib": {"title": "Werner\u2212 Wasik M, Tremont\u2212 Lukats IW, Sulman EP, Aldape KD, Curran WJ Jr, Mehta MP: A randomized trial of bevacizumab for newly diagnosed glioblastoma", "year": "2014"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:ruyezt5ZtCIC", "citedby": "3"}, {"bib": {"title": "Early viewing of noninferiority trials in progress", "year": "2005"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:EkHepimYqZsC", "citedby": "3"}, {"bib": {"title": "Effect of body mass index on outcomes in patients with Dukes B and C colon cancer: An analysis of NSABP randomized trials", "year": "2005"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:geHnlv5EZngC", "citedby": "3"}, {"bib": {"title": "Hypermethylation of BRCA1 promoter in sporadic breast cancer: comparison with BRCA1-associated hereditary breast cancer.", "year": "2002"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:lSLTfruPkqcC", "citedby": "3"}, {"bib": {"title": "House characteristics associated with gamma radiation and radon daughter working levels in eastern Pennsylvania", "year": "1987"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:9ZlFYXVOiuMC", "citedby": "3"}, {"bib": {"title": "Biomarker-driven oncology clinical trials: Key design elements, types, features, and practical considerations", "year": "2019"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:S16KYo8Pm5AC", "citedby": "2"}, {"bib": {"title": "Radiation Therapy Oncology Group RTOG 1008 A randomized phase II study of adjuvant concurrent radiation and chemotherapy versus radiation alone in resected high-risk malignant \u2026", "year": "2012"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:0EnyYjriUFMC", "citedby": "2"}, {"bib": {"title": "Does enrollment setting influence patient attributes and outcomes in RTOG prostate cancer trials?", "year": "2011"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:YsMSGLbcyi4C", "citedby": "2"}, {"bib": {"title": "Comments on: Yin W, Di G, Zhou L, Lu J, Liu G, Wu J, Shen K, Han Q, Shen Z, Shao Z. Time-varying pattern of recurrence risk for Chinese breast cancer patients", "year": "2009"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:1sJd4Hv_s6UC", "citedby": "2"}, {"bib": {"title": "Statistical issues in investigating prognostic and predictive markers for DCIS", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:P5F9QuxV20EC", "citedby": "2"}, {"bib": {"title": "Analysis of Cause-Specific Events in Competing Risks Survival Data", "year": "2003"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:fQNAKQ3IYiAC", "citedby": "2"}, {"bib": {"title": "Ballistic missile defense technology transfer for medical applications", "year": "1994"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:uWQEDVKXjbEC", "citedby": "2"}, {"bib": {"title": "Association of presalvage radiotherapy PSA levels after prostatectomy with outcomes of long-term antiandrogen therapy in men with prostate cancer", "year": "2020"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:0N-VGjzr574C", "citedby": "1"}, {"bib": {"title": "Transcriptome profiling of NRG Oncology/RTOG 9601: Validation of a prognostic genomic classifier in salvage radiotherapy prostate cancer patients from a prospective randomized \u2026", "year": "2020"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:Ug5p-4gJ2f0C", "citedby": "1"}, {"bib": {"title": "A randomized trial of selenium and vitamin E for primary prevention of non-melanoma skin cancer: Trial results and experience from a low-resource setting.", "year": "2017"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:2osOgNQ5qMEC", "citedby": "1"}, {"bib": {"title": "Building firm foundations for therapy development", "year": "2015"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:UHK10RUVsp4C", "citedby": "1"}, {"bib": {"title": "Reply to MC Chamberlain", "year": "2014"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:t6usbXjVLHcC", "citedby": "1"}, {"bib": {"title": "OM-067. A MOLECULAR PREDICTOR OF RESPONSE TO BEVACIZUMAB BASED ON ANALYSIS OF RTOG 0825, A PHASE III TRIAL COMPARING CHEMORADIATION WITH AND WITHOUT BEVACIZUMAB IN PATIENTS \u2026", "year": "2013"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:R3hNpaxXUhUC", "citedby": "1"}, {"bib": {"title": "Hazard of Recurrence among Women after Primary Breast Cancer Treatment\u2013A 10-Year Follow-up Using Data from SEER-Medicare", "year": "2013"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:YOwf2qJgpHMC", "citedby": "1"}, {"bib": {"title": "Comparison of futility monitoring methods using RTOG clinical trials", "year": "2011"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:LjlpjdlvIbIC", "citedby": "1"}, {"bib": {"title": "130 HAZARD OF PROSTATE CANCER-SPECIFIC MORTALITY OVER TIME FOLLOWING RADICAL PROSTATECTOMY", "year": "2010"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:Tiz5es2fbqcC", "citedby": "1"}, {"bib": {"title": "Does Cetuximab Improve Control of Advanced Head and Neck Cancer? A Second Look at the Randomized Trial by Bonner, et al.", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:1yQoGdGgb4wC", "citedby": "1"}, {"bib": {"title": "Understanding differences in the receipt of chemotherapy between African-American (AA) and white (W) patients with stage III colon cancer", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:5nxA0vEk-isC", "citedby": "1"}, {"bib": {"title": "Anxiety and depression among high-risk women in an MRI surveillance study", "year": "2006"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:ns9cj8rnVeAC", "citedby": "1"}, {"bib": {"title": "The role of BRCA1 promoter methylation in determining chemosensitivity in vitro", "year": "2006"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:mB3voiENLucC", "citedby": "1"}, {"bib": {"title": "FANCF promoter is methylated in human sporadic breast cancers.", "year": "2003"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:HoB7MX3m0LUC", "citedby": "1"}, {"bib": {"title": "Lymph Node-Negative Breast Cancer: Updated Findings From the National Surgical Adjuvant Breast and Bowel Project B-14 Randomized Trial", "year": "2001"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:blknAaTinKkC", "citedby": "1"}, {"bib": {"title": "Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors-Response", "year": "1997"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:z_wVstp3MssC", "citedby": "1"}, {"bib": {"title": "Breast cancer trials on trial: A case of conflicting ethical interests", "year": "1995"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:tuHXwOkdijsC", "citedby": "1"}, {"bib": {"title": "Association of PTEN Status with Response to Salvage Radiation Therapy with or without Anti-Androgen Therapy: A Study of RTOG 96-01", "year": "2020"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:FPJr55Dyh1AC", "citedby": "0"}, {"bib": {"title": "Survival Analysis II", "year": "2020"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:edDO8Oi4QzsC", "citedby": "0"}, {"bib": {"title": "Comparing Treatments in the Presence of Competing Risks Based on Life Years Lost", "year": "2019"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:oNZyr7d5Mn4C", "citedby": "0"}, {"bib": {"title": "original report abstract Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202", "year": "2019"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:WZBGuue-350C", "citedby": "0"}, {"bib": {"title": "Detecting a Survival Benefit to Dose Escalation\u2014Reply", "year": "2019"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:EYYDruWGBe4C", "citedby": "0"}, {"bib": {"title": "MA05. 09 PFS and Cardiac-Toxicity-Adjusted-PFS As Predictors of OS in Locally Advanced NSCLC Treated with Concurrent Chemoradiation", "year": "2018"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:BwyfMAYsbu0C", "citedby": "0"}, {"bib": {"title": "Cost effectiveness analysis of Oncotype DX testing in patients with synchronous unilateral primary breast cancer.", "year": "2018"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:tOudhMTPpwUC", "citedby": "0"}, {"bib": {"title": "Progression-free survival (PFS) and cardiac-toxicity-adjusted-PFS (CTA-PFS) as predictors of overall survival (OS) in locally advanced non-small cell lung cancers (LA-NSCLC \u2026", "year": "2018"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:TQgYirikUcIC", "citedby": "0"}, {"bib": {"title": "SURGERY FOR SIGMOID VOLVULUS: IS LAPAROSCOPY BENEFICIAL?", "year": "2018"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:4MWp96NkSFoC", "citedby": "0"}, {"bib": {"title": "Abstract P2-10-10: Oncotype Dx testing in patients with synchronous unilateral primary breast cancer", "year": "2018"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:ldfaerwXgEUC", "citedby": "0"}, {"bib": {"title": "Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis", "year": "2018"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:b1wdh0AR-JQC", "citedby": "0"}, {"bib": {"title": "NRG Oncology/RTOG 0415, Hypofractionation in Patients with Low-Risk Prostate Cancer: Are Patient Reported Outcomes the Practice Change Tipping Point?", "year": "2017"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:7T2F9Uy0os0C", "citedby": "0"}, {"bib": {"title": "Disease free survival (DFS) as a surrogate for Overall Survival (OS) in Localized Prostate Cancer (CaP)-Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP \u2026", "year": "2016"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:4TOpqqG69KYC", "citedby": "0"}, {"bib": {"title": "Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1", "year": "2016"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:BUYA1_V_uYcC", "citedby": "0"}, {"bib": {"title": "Dual targeting of the autophagic regulatory circuitry in gliomas with repurposed drugs elicits cell-lethal autophagy and therapeutic benefit", "year": "2015"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:AvfA0Oy_GE0C", "citedby": "0"}, {"bib": {"title": "ATCT-29 Investigating the effect of reirradiation or systemic therapy in patients with GBM after tumor progression: a secondary analysis of the NRG Oncology/RTOG 0525", "year": "2015"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:nrtMV_XWKgEC", "citedby": "0"}, {"bib": {"title": "Modeling Long-term Outcomes and Treatment Effects After Androgen Deprivation Therapy for Prostate Cancer", "year": "2015"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:-f6ydRqryjwC", "citedby": "0"}, {"bib": {"title": "Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial", "year": "2015"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:ML0RJ9NH7IQC", "citedby": "0"}, {"bib": {"title": "PD-0422: Validating a 2 year survival prediction model for laryngeal carcinoma patients in a clinical care and trial setting", "year": "2015"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:BrmTIyaxlBUC", "citedby": "0"}, {"bib": {"title": "Assessing treatment benefit with competing risks not affected by the randomized treatment", "year": "2015"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:GnPB-g6toBAC", "citedby": "0"}, {"bib": {"title": "Competing Risks and Their Applications in Cancer Clinical Trials", "year": "2014"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:2P1L_qKh6hAC", "citedby": "0"}, {"bib": {"title": "Bevacizumab bei neu diagnostiziertem Glioblastom", "year": "2014"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:qUcmZB5y_30C", "citedby": "0"}, {"bib": {"title": "Pr\u00e9diction dynamique de progression de cancer individualis\u00e9e selon des sc\u00e9narios de nouveaux traitements: d\u00e9veloppement et validation scientifique", "year": "2014"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:maZDTaKrznsC", "citedby": "0"}, {"bib": {"title": "A randomized trial of bevacizumab for newly diagnosed glioblastoma", "year": "2014"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:Z5m8FVwuT1cC", "citedby": "0"}, {"bib": {"title": "Lessons Learned From Radiation Therapy Oncology Group 0525 Trial Reply", "year": "2014"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:XiVPGOgt02cC", "citedby": "0"}, {"bib": {"title": "NEURO/MEDICAL ONCOLOGY", "year": "2013"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:zLWjf1WUPmwC", "citedby": "0"}, {"bib": {"title": "OMICS AND PROGNSTIC MARKERS", "year": "2013"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:qjMakFHDy7sC", "citedby": "0"}, {"bib": {"title": "NCI-RTOG Translational-Program Strategic Guidelines for the Early Stage Development of Radiosensitizers", "year": "2012"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:PELIpwtuRlgC", "citedby": "0"}, {"bib": {"title": "Zauj\u00edmavosti zo zahrani\u010dnej literat\u00fary", "year": "2012"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:wbdj-CoPYUoC", "citedby": "0"}, {"bib": {"title": "EP-01. ETHNIC DISPARITIES IN THE ACCESSIBILITY OF NEUROSURGICAL SERVICES AT A COUNTY ACADEMIC HOSPITAL", "year": "2011"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:4JMBOYKVnBMC", "citedby": "0"}, {"bib": {"title": "Surrogate End-points for Prostate Cancer Specific Survival: Superiority of the Interval to Biochemical Failure: An Analysis of RTOG 9202 and 9413", "year": "2011"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:aqlVkmm33-oC", "citedby": "0"}, {"bib": {"title": "Variation over time and interdependence between disease progression and death among patients with glioblastoma (GBM) on RTOG 0525.", "year": "2011"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:Wp0gIr-vW9MC", "citedby": "0"}, {"bib": {"title": "Predictors of Local Recurrence in a Population-Based Cohort of Women with Ductal Carcinoma In Situ Treated with Breast Conserving Surgery Alone", "year": "2011"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:gsN89kCJA0AC", "citedby": "0"}, {"bib": {"title": "Abstract P6-09-02: Risk of Breast Cancer Associated with Hormone Replacement Therapy Use Differs by Age, Race, and Breast Density", "year": "2010"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:35r97b3x0nAC", "citedby": "0"}, {"bib": {"title": "Race and the influence of p53 as a marker of prognosis in women of lower SES with breast cancer.", "year": "2010"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:VOx2b1Wkg3QC", "citedby": "0"}, {"bib": {"title": "p53 as a marker of prognosis in African American (AA) women with breast cancer", "year": "2009"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:WqliGbK-hY8C", "citedby": "0"}, {"bib": {"title": "Introduction to Statistical Methods for Clinical Trials", "year": "2009"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:SdhP9T11ey4C", "citedby": "0"}, {"bib": {"title": "Tamoxifen Chemoprevention Treatment and Time to First Diagnosis of Estrogen Receptor\u2013Negative Breast Cancer", "year": "2009"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:NMxIlDl6LWMC", "citedby": "0"}, {"bib": {"title": "Factors Associated with Non-cancer Mortality in Advanced Head and Neck Cancer: A Competing Risks Analysis", "year": "2008"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:u5HHmVD_uO8C", "citedby": "0"}, {"bib": {"title": "The use of a novel, web-based educational platform facilitates intra-operative training in a surgical oncology fellowship program", "year": "2008"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:UxriW0iASnsC", "citedby": "0"}, {"bib": {"title": "Estrogen receptor \u03b1 (ER), BRCA1 and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:ZuybSZzF8UAC", "citedby": "0"}, {"bib": {"title": "Book Review: Lemuel A Moye 2006: Statistical Monitoring of Clinical Trials: Fundamentals for Investigators. Springer. $59.94 ISBN 0-387-27781-1", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:p2g8aNsByqUC", "citedby": "0"}, {"bib": {"title": "Health-related quality of life among high-risk women in an MRI surveillance study", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:hFOr9nPyWt4C", "citedby": "0"}, {"bib": {"title": "Content and method of parental disclosure of genetic risk to young adult and minor children in BRCA families", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:MXK_kJrjxJIC", "citedby": "0"}, {"bib": {"title": "The Editors of Clinical Trials are indebted to those individuals who generously gave up their valuable time to review the manuscripts submitted to the journal. The success of \u2026", "year": "2007"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:7PzlFSSx8tAC", "citedby": "0"}, {"bib": {"title": "Disclosure patterns and decision making preferences in BRCA 112 mutation carriers with young adult and minor children.", "year": "2006"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:mvPsJ3kp5DgC", "citedby": "0"}, {"bib": {"title": "Disclosure patterns and decision making preferences in BRCA 1/2 mutation carriers with young adult and minor children", "year": "2006"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:08ZZubdj9fEC", "citedby": "0"}, {"bib": {"title": "BRCA1 promoter methylation confers sensitivity to cisplatin in vitro", "year": "2005"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:olpn-zPbct0C", "citedby": "0"}, {"bib": {"title": "Molecular pathogenesis of breast cancer in women of African ancestry", "year": "2005"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:f2IySw72cVMC", "citedby": "0"}, {"bib": {"title": "Impact of ethnic neutropenia disparity analysis in NSABP breast trials of postoperative doxorubicin (A)/cyclophosphamide (C)", "year": "2005"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:zYLM7Y9cAGgC", "citedby": "0"}, {"bib": {"title": "Epigenetic regulation of estrogen receptor in Nigerian breast cancer: implication for hormonal treatment of breast cancer in resource poor countries", "year": "2005"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:9yKSN-GCB0IC", "citedby": "0"}, {"bib": {"title": "Prevalence of functional impairment among prostate cancer patients determined by comprehensive geriatric assessment (CGA): Baseline data for a prospective study of androgen \u2026", "year": "2004"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:JQOojiI6XY0C", "citedby": "0"}, {"bib": {"title": "DEVELOPING RATIONAL THERAPY FOR BRCA1 AND BRCA2 ASSOCIATED BREAST CANCER. SHOULD BIOLOGY MATTER?", "year": "2003"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:kz9GbA2Ns4gC", "citedby": "0"}, {"bib": {"title": "Mammographic density and obesity as risk factors for invasive breast cancer following ductal carcinoma in situ (DCIS)", "year": "2003"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:hMod-77fHWUC", "citedby": "0"}, {"bib": {"title": "ORIGINAL REPORTS-Gastrointestinal Cancer-Prognosis After Rectal Cancer in Blacks and Whites Participating in Adjuvant Therapy Randomized Trials", "year": "2003"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:D_sINldO8mEC", "citedby": "0"}, {"bib": {"title": "Hypermethylation of estrogen receptor-alpha promoter is associated with BRCA1 methylation in estrogen receptor-negative breast cancers", "year": "2003"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:tS2w5q8j5-wC", "citedby": "0"}, {"bib": {"title": "Study accrual among elderly cancer patients", "year": "2002"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:bnK-pcrLprsC", "citedby": "0"}, {"bib": {"title": "ORIGINAL REPORTS-Breast Cancer-Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast \u2026", "year": "2002"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:bEWYMUwI8FkC", "citedby": "0"}, {"bib": {"title": "Mammographic density and breast cancer after ductal carcinoma in situ.", "year": "2001"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:fPk4N6BV_jEC", "citedby": "0"}, {"bib": {"title": "Relationship of body mass index to outcomes after lymph node-negative, estrogen receptor positive breast cancer.", "year": "2001"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:J_g5lzvAfSwC", "citedby": "0"}, {"bib": {"title": "CORRESPONDENCE-Response-Re: Prognosis and Treatment of Patients With Breast Tumors of One Centimeter or Less and Negative Axillary Lymph Nodes", "year": "2001"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:LI9QrySNdTsC", "citedby": "0"}, {"bib": {"title": "Racial/Ethnic Background and Benefits of Adjuvant Therapy for Breast Cancer", "year": "2000"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:i2xiXl-TujoC", "citedby": "0"}, {"bib": {"title": "Janis Davidson, Judith Bliss", "year": "2000"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:hC7cP41nSMkC", "citedby": "0"}, {"bib": {"title": "Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial", "year": "2000"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:HDshCWvjkbEC", "citedby": "0"}, {"bib": {"title": "Obstructive sleep apnoea", "year": "1999"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:e5wmG9Sq2KIC", "citedby": "0"}, {"bib": {"title": "Biomathematical Explorations into Long-Term Tamoxifen Efficacy in the Treatment of Early Breast Cancer", "year": "1999"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:_Re3VWB3Y0AC", "citedby": "0"}, {"bib": {"title": "Analysis of Recurrent Episodes of Acute Otitis Media: An Application of Multiple Failure Time Proportional Hazards Models", "year": "1999"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:WbkHhVStYXYC", "citedby": "0"}, {"bib": {"title": "Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17", "year": "1999"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:isC4tDSrTZIC", "citedby": "0"}, {"bib": {"title": "Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer-Response", "year": "1998"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:VLnqNzywnoUC", "citedby": "0"}, {"bib": {"title": "Early Closure of a Clinical Trial When the Treatment Does Not Appear to be Beneficial: Frequentist and Bayesian Perspectives", "year": "1997"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:bFI3QPDXJZMC", "citedby": "0"}, {"bib": {"title": "106 Early termination of a clinical trial when there is evidence that the treatment will ultimately not prove beneficial: protocol b-14 of the national surgical adjuvant breast \u2026", "year": "1997"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:O3NaXMp0MMsC", "citedby": "0"}, {"bib": {"title": "Response-Re: Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive Tumors", "year": "1997"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:d1gkVwhDpl0C", "citedby": "0"}, {"bib": {"title": "Multiple endpoint problems in survival analysis", "year": "1994"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:kzcrU_BdoSEC", "citedby": "0"}, {"bib": {"title": "Findings From Recent National Surgical Adjuvant Breast and Bowel Project Adjuvant Studies in Stage I", "year": "1990"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:kuK5TVdYjLIC", "citedby": "0"}, {"bib": {"title": "Efficacy of Systemic Adjuvant Therapy for Breast", "year": "1990"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:dhFuZR0502QC", "citedby": "0"}, {"bib": {"title": "CORRELATES OF RADON DAUGHTER CONTAMINATION OF PENNSYLVANIA RESIDENTS", "year": "1987"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:j8SEvjWlNXcC", "citedby": "0"}, {"bib": {"title": "GAMMA-RAY EXPOSURE LEVELS IN READING PRONG BASEMENTS BY HOUSE CHARACTERISTICS", "year": "1987"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:ye4kPcJQO24C", "citedby": "0"}, {"bib": {"title": "RADON DAUGHTER WORKING LEVELS BY HOUSE CHARACTERISTICS IN RESIDENCES ON THE READING PRONG", "year": "1987"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:CHSYGLWDkRkC", "citedby": "0"}, {"bib": {"title": "European Society for Medical Oncology Volume 15, No. 6 June 2004"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:XoXfffV-tXoC", "citedby": "0"}, {"bib": {"title": "Late Breaking Abstracts"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:PoWvk5oyLR8C", "citedby": "0"}, {"bib": {"title": "NRG Oncology/RTOG 0415, Phase III Non-Inferiority Study Comparing 2 Fractionation Schedules in Patients with Low-Risk Prostate Cancer: Prostate Specific Quality of Life Results"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:e_rmSamDkqQC", "citedby": "0"}, {"bib": {"title": "Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:lmc2jWPfTJgC", "citedby": "0"}, {"bib": {"title": "Appendix 2: Definitions of \u201ccorrect\u201d and \u201cincorrect\u201d answers for knowledge questions, and details regarding construction of the knowledge score."}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:tYavs44e6CUC", "citedby": "0"}, {"bib": {"title": "Department of Public Health Sciences"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:evX43VCCuoAC", "citedby": "0"}, {"bib": {"title": "Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer Does Not Affect Outcome"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:Y5dfb0dijaUC", "citedby": "0"}, {"bib": {"title": "Tamoxifen for breast cancer may reduce CHD mortality"}, "source": "citations", "id_citations": "QeDjEOAAAAAJ:dshw04ExmUIC", "citedby": "0"}]}